ASLAN Pharmaceuticals

ASLAN Pharmaceuticals is a clinical-stage biopharmaceutical company headquartered in Singapore, focusing on immunology and oncology. Founded in 2010, the company is dedicated to developing innovative treatments aimed at improving patient outcomes. Its clinical portfolio includes ASLAN004, a monoclonal antibody therapy for atopic dermatitis and other immunological conditions, as well as a small molecule inhibitor for oncology applications. ASLAN Pharmaceuticals collaborates with industry partners such as Almirall, Array BioPharma, Bristol-Myers Squibb, and CSL Limited to enhance its research and development efforts. The company aims to create novel medicines for global markets, addressing significant unmet medical needs.